PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsEssential tremor
MeSH D020329 - essential tremor
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009069:Movement disorders
2 Companies
2 Drugs
$
Success rate
D020329: 
Essential tremor
32 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPropranolol Propranolol  1987-10-07   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-12-01   
MylanPropranolol Propranolol  1985-11-19   
Rising PharmaceuticalsPropranolol Propranolol  2007-02-15   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-03-04   
SandozPropranolol Propranolol  1988-07-05   
WyethPropranolol Inderal  1982-01-01   
Propranolol, Hydrochlorothiazide Inderide  1985-07-03   
Propranolol, Hydrochlorothiazide Inderide-  1982-01-01   
Merck & CoPropranolol Propranolol  1985-08-06   
Zydus TherapeuticsPropranolol Propranolol  2011-03-25   
Warner ChilcottPropranolol Propranolol  1986-09-15   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-01-26   
Chartwell PharmaceuticalsPropranolol Propranolol  1986-06-13   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-08-26   
Impax LaboratoriesPropranolol Propranolol  1988-04-06   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
18%
3/17
Phase 3
25%
1/4
Approved: 1Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Hydrochlorothiazide
Mylan
Propranolol
Merck & Co
Propranolol
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use